SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report이라크 의료 종사자에서 SARS-CoV-2 백신 획기적인 재감염: 사례 보고Case Reports Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] affected Breakthrough infection Case report circulating variants completion COVID-19 COVID-19 pandemic delta variant Effectiveness globe Health health worker health-care Infection Intervention Iraq Isolation many case many cases mediated immunity Patient question raised Reinfection reported Respiratory illness RT-PCR SARS-CoV-2 SARS-CoV-2 vaccine scarcity severe respiratory illness symptom severity the SARS-CoV-2 vaccinated individuals vaccination Vaccine vaccine breakthrough infection vaccine breakthrough infections vaccine-mediated immunity variants variants. Wuhan Wuhan, China [DOI] 10.1080/21645515.2022.2055947 PMC 바로가기 [Article Type] Case Reports
Directly immersible silicon photonic probes: Application to rapid SARS-CoV-2 serological testingArticle Published on 2022-11-012022-11-15 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-human IgG antibody application binding bovine Broad-band Mach-Zehnder interferometry correlated demonstrated Detection limit domain ELISA fiber human serum humanized Immersible sensor include indicated Label-free detection opposite point-of-care probe Protein RBD reaction Real-time monitoring resulting SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 RBD Serological testing serum albumin silicon Silicon nitride waveguides. spike the antibody vaccinated individuals was determined [DOI] 10.1016/j.bios.2022.114570 PMC 바로가기
Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022Article Published on 2022-11-012022-11-15 Journal: Eurosurveillance [Category] SARS, 변종, 진단, [키워드] Breakthrough infection dose evaluated HCW healthcare worker Infection infections neutralising neutralising antibody neutralising antibody titre omicron Omicron variants, neutralising antibodies SARS-CoV-2 SARS-CoV-2. uninfected vaccinated individual vaccinated individuals Vaccine variant variants wild type [DOI] 10.2807/1560-7917.ES.2022.27.44.2200785 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, FloridaArticle Published on 2022-10-292022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] acute infection acute respiratory syndrome association average booster caused Characteristics conducted Contact Contact tracing coronavirus coronavirus 2 Delta delta variant Epidemic evaluate exhibited Florida genomes Immunity Infection interquartile range Lineage majority occurred Patient Phylogenetic Phylogenetic analysis public health question raising regression analysis respiratory SARS-CoV-2 SARS-CoV2 sequence sequenced Spread threshold through contact Transmissibility Transmission vaccinated individual vaccinated individuals vaccination vaccination. Vaccine vaccine dose Viral RNA viral RNA quantification were used [DOI] 10.1093/cid/ciac197 PMC 바로가기
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccinationArticle Published on 2022-10-282022-11-15 Journal: Science Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Antibody Response B.1.617.2 BAL Blood booster vaccination Breakthrough infection Bronchoalveolar lavage fluid cellular immunity circulating Combination convalescent COVID-19 COVID-19 vaccine D614G Delta demonstrated effective elicit hospitalized patients humoral immune response Immunity immunization individual induce Infection mRNA vaccination mucosal neutralizing antibody Neutralizing antibody response neutralizing antibody responses offer omicron Reinfection respiratory respiratory tract response robust SARS-CoV-2 severe disease significantly lower Support T cell T cell response the SARS-CoV-2 vaccinated individuals variant variants of concern virus VOCs with COVID-19 [DOI] 10.1126/sciimmunol.add4853 PMC 바로가기
Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3Article Published on 2022-10-272022-11-15 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Ablation addition affected Antigen CD8 CD8+ T cell changes in convalescent COVID-19 demonstrated epitope genetics Immunity immunodominant less leukocyte neutralization observation omicron raised recognize reduction in SARS-CoV-2 sequence suggested T cell T cell response T cell responses T cells the SARS-CoV-2 vaccinated individuals Vaccine-induced immunity variant [DOI] 10.1038/s41467-022-34180-1 PMC 바로가기
Longitudinal Serological Surveillance for COVID-19 Antibodies after Infection and VaccinationArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] 진단, [키워드] Ad26.COV2.S vaccine addition analyzed Anti-spike anti-spike antibody antibody Antibody titer association booster vaccination booster vaccinations Breakthrough infection breakthrough infections can be used Characteristics Cohort Complete conducted Confirmed COVID-19 infection COVID-19 COVID-19 infection COVID-19 infections COVID-19 pandemic Defense evaluate event events exhibited Health care system immunization include Infection infection risk infections Infectious disease Infectious disease. information longitudinal mRNA mRNA vaccines occurred participant positively correlated Prevalence receive receiving reported Research risk significantly social distancing subject subjects the timing threshold vaccinated individuals vaccination vaccination responses Vaccination strategy vaccinee vaccinees [DOI] 10.1128/spectrum.02026-22 PMC 바로가기
Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated IndividualsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Alpha variant analysis Asia association B.1.1.7 lineage B.1.617.2 Breakthrough infection breakthrough infection. circulating Cluster Complete conducted coronavirus disease COVID-19 Delta delta variant demonstrated determine diagnostic dominant epidemiologically evaluate Evidence Factor genomic genotyping highest increase in independent individual individuals Infection Infectious virus information Isolation Lineage New York PCR peaked performed phylogenetic clusters positive real-time reverse transcriptase Replication SARS-CoV-2 SARS-CoV-2 lineage secretion sequence spread to subset Surveillance the SARS-CoV-2 Transmission transmission clusters transmission of SARS-CoV-2 vaccinated individual vaccinated individuals vaccination rate Viral load viral RNA load viral titer virological assessment virus Virus titration VoC [DOI] 10.1128/spectrum.00563-22 PMC 바로가기
Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New JerseyArticle Published on 2022-10-262022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료기술, [키워드] acute respiratory syndrome antibody antibody resistance attack rate B.1.351 B.1.526 Care caused characteristic Clinical use collected Community Complete coronavirus COVID-19 Critical E484K mutation Evidence Examining exhibit exhibited hcp Health highlight individual infected individuals Infection Inpatient Lineage loss of activity monoclonal antibody Mutation N-terminal domain neutralization capacity Neutralizing antibody response neutralizing capacity New nosocomial NTD outbreak P.1 Patient plasma positive professional professionals proportion pseudovirus psychiatric facility Receptor binding domain reported reverse transcription robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sera Spike protein Symptom symptomatic COVID-19 disease tested the SARS-CoV-2 the United State treat vaccinated individual vaccinated individuals vaccination Vaccine variant variants of concern variants of concern. VOCs wild type [DOI] 10.1128/mbio.02141-22 PMC 바로가기
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesArticle Published on 2022-10-252022-11-15 Journal: Cell Reports [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Administering boost caused coronavirus COVID-19 CP: Immunology Donor dose elicit elicited extended interval humoral Humoral response humoral responses individual Infection long interval mRNA vaccine observé omicron regimen robust SARS-CoV-2 SARS-CoV-2 BNT162b2 second dose significantly spike glycoproteins third mRNA vaccine dose vaccinated individuals variant variants of concern variants of concern. VoC VOCs [DOI] 10.1016/j.celrep.2022.111554 PMC 바로가기